Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TE vs GSK✓SelectedUSD · GSKTE vs GSK performance historyLatest closeAs of-14.73%11/20
Stock and ETF performance explorer

TE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-35.7%
GSK return
+53.4%
Excess return
-89.0%
Maximum drawdown
-90.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-14.7%-0.1%-14.6%-14.7%
7D-42.4%-5.3%-37.1%-42.8%
30D-53.8%-3.7%-50.1%-53.9%
3M-74.8%-7.3%-67.5%-74.8%
6M-87.4%-4.2%-83.1%-87.4%
YTD-83.5%+0.9%-84.4%-83.6%
1Y-59.6%+7.3%-66.8%-60.3%
3Y-35.7%+52.7%-88.4%-54.5%
All-35.7%+53.4%-89.0%-54.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling